S 3021
116th Congress
Senate
Health
Consumer affairs
Drug safety, medical device, and laboratory regulation
Grain
Nutrition and diet
Prescription drugs
Gluten in Medicine Disclosure Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 11, 2019
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Gluten in Medicine Disclosure Act of 2019
This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1) states that the drug contains such an ingredient, and (2) identifies the type of grain from which the ingredient is derived.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 3021: Gluten in Medicine Disclosure Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-3021/
"S. 3021: Gluten in Medicine Disclosure Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3021/.
S. 3021, 116th Cong. (2026), https://openamerica.io/bill/116-S-3021/.
[S. 3021: Gluten in Medicine Disclosure Act of 2019](https://openamerica.io/bill/116-S-3021/)